Brandstetter R D, Tamarin F M, Rangraj M S, Ruiz M, Giampietro J
Chest. 1984 Oct;86(4):644-5. doi: 10.1378/chest.86.4.644.
Fatal pulmonary hemorrhage occurred on the eighth day of moxalactam therapy. No other pharmacologic agent or obvious cause could be attributed to the hemoptysis. Moxalactam-induced pulmonary hemorrhage should be included in the differential diagnosis of an infiltrate when moxalactam is being administered.
致命性肺出血发生在羟羧氧酰胺菌素治疗的第八天。咯血未发现可归因于其他任何药物或明显病因。使用羟羧氧酰胺菌素时，在鉴别诊断浸润性病变时应考虑到羟羧氧酰胺菌素引起的肺出血。
